Dennis Polk - Nov 1, 2022 Form 4 Insider Report for Concentrix Corp (CNXC)

Role
Director
Signature
/s/ Andrew A. Farwig, Attorney-in-Fact
Stock symbol
CNXC
Transactions as of
Nov 1, 2022
Transactions value $
-$836,969
Form type
4
Date filed
11/3/2022, 05:30 PM
Previous filing
Oct 28, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNXC Common Stock Options Exercise $379K +10K +64.49% $37.94 25.5K Nov 1, 2022 Direct
transaction CNXC Common Stock Sale -$547K -4.52K -17.74% $120.85 21K Nov 1, 2022 Direct F1, F2
transaction CNXC Common Stock Sale -$285K -2.34K -11.16% $121.51 18.6K Nov 1, 2022 Direct F1, F3
transaction CNXC Common Stock Sale -$324K -2.64K -14.18% $122.72 16K Nov 1, 2022 Direct F1, F4
transaction CNXC Common Stock Sale -$60.6K -490 -3.06% $123.70 15.5K Nov 1, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNXC Employee Stock Option (Right to Buy) Options Exercise $0 -10K -27.08% $0.00 26.9K Nov 1, 2022 Common Stock 10K $37.94 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $120.19 to $121.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $121.30 to $121.85, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.30 to $123.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.50 to $123.83, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F6 The stock option vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.